Alessio Bruni

1.9k total citations
65 papers, 705 citations indexed

About

Alessio Bruni is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alessio Bruni has authored 65 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 21 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alessio Bruni's work include Advanced Radiotherapy Techniques (17 papers), Prostate Cancer Treatment and Research (17 papers) and Lung Cancer Diagnosis and Treatment (16 papers). Alessio Bruni is often cited by papers focused on Advanced Radiotherapy Techniques (17 papers), Prostate Cancer Treatment and Research (17 papers) and Lung Cancer Diagnosis and Treatment (16 papers). Alessio Bruni collaborates with scholars based in Italy, Switzerland and France. Alessio Bruni's co-authors include Lorenzo Livi, Paolo Borghetti, Luca Triggiani, Beatrice Detti, Stefano Maria Magrini, Vieri Scotti, Giulio Francolini, Patrizia Ciammella, Filippo Alongi and Gianluca Ingrosso and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Alessio Bruni

58 papers receiving 700 citations

Peers

Countries citing papers authored by Alessio Bruni

Since Specialization

Citations

This map shows the geographic impact of Alessio Bruni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessio Bruni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessio Bruni more than expected).

Fields of papers citing papers by Alessio Bruni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessio Bruni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessio Bruni. The network helps show where Alessio Bruni may publish in the future.

Co-authorship network of co-authors of Alessio Bruni

This figure shows the co-authorship network connecting the top 25 collaborators of Alessio Bruni. A scholar is included among the top collaborators of Alessio Bruni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessio Bruni. Alessio Bruni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Locally advanced NSCLC: overview of real-world pattern of recurrence in durvalumab era (LEOPARD trial) 2025 ·Lung Cancer ·Patrizia Ciammella, Francesco Iori, Paolo Borghetti, Marco Galaverni, (unknown), Marcello Tiseo, Maria Pagano, Matteo Sepulcri, Vieri Scotti, (unknown), Michela Marcenaro, (unknown), Valerio Nardone, A. Botti, Salvatore Cozzi, Alessio Bruni	1
2	PERSIAN trial: Early results from a randomized phase II trial testing apalutamide and stereotactic body radiation therapy for low-burden, metastatic, hormone-sensitive prostate cancer. 2025 ·Journal of Clinical Oncology ·Giulio Francolini, Vanessa Di Cataldo, (unknown), Saverio Caini, Alessio Bruni, (unknown), Matteo Augugliaro, Roberto Iacovelli, Luca Tagliaferri, Nicola Battelli, Gianluca Ingrosso, Angelo Porreca, Marco Trovò, Giuseppe Fornarini, Giuseppe Carlo Iorio, Alessia Guarneri, Michele Sisani, Lorenzo Antonuzzo, (unknown), Lorenzo Livi, (unknown)	3
3	Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 2024 ·Current Oncology ·Alessio Bruni, Vieri Scotti, (unknown), Federica Bertolini, (unknown), Emanuela Olmetto, Chiara Bennati, Francesco Cuccia, (unknown), Niccolò Giaj‐Levra, Marcello Tiseo, Patrizia Ciammella, Stefano Vagge, Marco Galaverni, Antonio Pontoriero, Serena Badellino, Ruggero Spoto, (unknown), Paolo Borghetti	1
4	Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach 2024 ·SHILAP Revista de lepidopterología ·(unknown), Fabiana Perrone, (unknown), Frank Lohr, Marcello Tiseo, Alessio Bruni	0
5	Dose‐intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial 2024 ·Cancer ·Matthias Gückenberger, Charlotte Billiet, Daniel Schnell, Ciro Franzese, Mateusz Spałek, Susanne Rogers, Jean‐Jacques Stelmes, Daniel M. Aebersold, Hossein Hemmatazad, Frank Zimmermann, (unknown), Thomas Zilli, Alessio Bruni, Brigitta G. Baumert, (unknown), Philipp Gut, Robert Förster, Indira Madani	14
6	ARTO trial: Overall survival analysis from a randomized phase II trial testing the benefit of adding stereotactic body radiotherapy to abiraterone acetate in patients with oligometastatic castrate-resistant prostate cancer. 2024 ·Journal of Clinical Oncology ·Giulio Francolini, Vanessa Di Cataldo, (unknown), Beatrice Detti, Saverio Caini, Alessio Bruni, Gianluca Ingrosso, Rolando Maria D’Angelillo, A.R. Alitto, Matteo Augugliaro, Luca Triggiani, Silvana Parisi, Gaetano Facchini, Marco Banini, Gabriele Simontacchi, Isacco Desideri, Icro Meattini, Richard K. Valicenti, Lorenzo Livi	0
7	Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC study 2024 ·La radiologia medica ·Valerio Nardone, Alessio Bruni, Davide Franceschini, (unknown), Stefano Vagge, Patrizia Ciammella, Matteo Sepulcri, (unknown), Elisa D’Angelo, Giuseppina De Marco, (unknown), (unknown), (unknown), Cesare Guida, (unknown), Paolo Borghetti, (unknown)	1
8	PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality? 2023 ·Journal of Clinical Medicine ·Luca Urso, Luca Filippi, Angelo Castello, Maria Cristina Marzola, Mirco Bartolomei, Corrado Cittanti, Luigia Florimonte, Massimo Castellani, Paolo Andrea Zucali, Alessio Bruni, Roberto Sabbatini, Massimo Dominici, Stefano Panareo, Laura Evangelista	9
9	Dissecting Immunotherapy Strategies for Small Cell Lung Cancer: Antibodies, Ionizing Radiation and CAR-T 2022 ·International Journal of Molecular Sciences ·Giorgia Guaitoli, Giovanni Neri, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alessio Bruni, Massimo Dominici, Federica Bertolini	2
10	Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment Radiomodulation 2022 ·Current Oncology ·(unknown), Alessio Bruni, Salvatore Cozzi, Patrizia Ciammella, (unknown), Luca Boldrini, Carlo Greco, Valerio Nardone, Viola Salvestrini, Isacco Desideri, Francesca De Felice, Cinzia Iotti	12
11	1369P Biochemical outcomes from ARTO trial (NCT03449719) a phase II randomized trial testing association between abiraterone acetate and stereotactic body radiation therapy in castrate-resistant prostate cancer patients 2022 ·Annals of Oncology ·Giulio Francolini, (unknown), Vanessa Di Cataldo, Saverio Caini, A.R. Alitto, Silvana Parisi, (unknown), Alessio Bruni, (unknown), Giorgia Timon, Andrea Gaetano Allegra, (unknown), Viola Salvestrini, (unknown), (unknown), Luca Visani, Carlotta Becherini, Isacco Desideri, Icro Meattini, Lorenzo Livi	1
12	147P Chemo-immunotherapy with or without consolidative radiotherapy in extensive-stage small cell lung cancer: An initial report of clinical outcome and safety 2022 ·Annals of Oncology ·Alessio Bruni, (unknown), Elisa D’Angelo, (unknown), (unknown), (unknown), Andrea Cappelli, Frank Lohr, Massimo Dominici, Giorgia Guaitoli	2
13	Impact of Gastrointestinal Side Effects on Patients’ Reported Quality of Life Trajectories after Radiotherapy for Prostate Cancer: Data from the Prospective, Observational Pros-IT CNR Study 2021 ·Cancers ·Marianna Noale, Alessio Bruni, Luca Triggiani, Michela Buglione, Filippo Bertoni, (unknown), Rodolfo Montironi, Renzo Corvò, Vittorina Zagonel, Angelo Porreca, Pierfrancesco Bassi, Mauro Gacci, Giario Conti, Stefania Maggi, Stefano Maria Magrini, (unknown)	5
14	Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 2021 ·La radiologia medica ·Anna Merlotti, Alessio Bruni, Paolo Borghetti, Sara Ramella, Vieri Scotti, Marco Trovò, Rita Chiari, Frank Lohr, Umberto Ricardi, Emilio Bria, Giovanni Pappagallo, Rolando Maria D’Angelillo, Stefano Arcangeli	19
15	Current radiotherapy techniques in NSCLC: challenges and potential solutions 2020 ·Expert Review of Anticancer Therapy ·Niccolò Giaj‐Levra, Paolo Borghetti, Alessio Bruni, Patrizia Ciammella, Francesco Cuccia, Alessandra Fozza, Davide Franceschini, Vieri Scotti, Stefano Vagge, Filippo Alongi	33
16	Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series 2020 ·Clinical & Translational Oncology ·Giulio Francolini, Beatrice Detti, Marta Bottero, Thomas Zilli, Andrea Lancia, Alessio Bruni, Simona Borghesi, (unknown), Paolo Castellucci, Stefano Fanti, Andrea Riccardo Filippi, Maria Ausilia Teriaca, (unknown), Cynthia Aristei, Ercole Mazzeo, Lorenzo Livi, Gianluca Ingrosso	12
17	492P A multicenter LArge retrospectIve daTabase on the personalization of Stereotactic ABlative Radiotherapy for lung metastases from colorectal cancer: Early results from the LaIT-SABR study 2020 ·Annals of Oncology ·Luca Nicosia, Michele Rigo, Davide Franceschini, Marta Scorsetti, (unknown), Mattia Falchetto Osti, (unknown), V. Vavassori, Paolo Borghetti, (unknown), Alessio Bruni, (unknown), Frank Lohr, (unknown), Ernesto Maranzano, Berardino De Bari, Rosario Mazzola, Filippo Alongi	1
18	Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 2019 ·Journal of Neuro-Oncology ·Sara Pedretti, Laura Masini, (unknown), Luca Triggiani, Marco Krengli, Bruno Meduri, Luigi Pirtoli, Paolo Borghetti, (unknown), N. Riva, Roberto Gatta, Vincenzo Fusco, Silvia Scoccianti, Alessio Bruni, Umberto Ricardi, Riccardo Santoni, Stefano Maria Magrini, Michela Buglione	5
19	Radiation therapy in small cell lung cancer: a national Italian survey 2018 ·La radiologia medica ·(unknown), Patrizia Ciammella, Giorgia Timon, Alessio Bruni, Davide Franceschini, Paolo Borghetti, (unknown), Carlo Greco, Vieri Scotti, Marco Trovò	5
20	Hypofractionated radiation therapy in the management of locally advanced NSCLC: a narrative review of the literature on behalf of the Italian Association of Radiation Oncology (AIRO)—Lung Working Group 2018 ·La radiologia medica ·(unknown), Rosario Mazzola, Patrizia Ciammella, Giorgia Timon, Alessandra Fozza, Davide Franceschini, Federico Navarria, Alessio Bruni, Marco Perna, Niccolò Giaj‐Levra, Filippo Alongi, Vieri Scotti, Marco Trovò	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact